ASX - FDA Approves Enhancements to EVERLAST™ Trial
Sydney AUSTRALIA 12 August 2008: Ventracor Limited (ASX:VCR) today announced that the US Food and Drug Administration (FDA) has approved several enhancements to the EVERLAST™ Destination Therapy (DT) Trial of the ...
